{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:43:34Z","timestamp":1792622614473,"version":"4.5.0"},"reference-count":32,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2018.0106","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T10:05:49Z","timestamp":1520849149000},"source":"Crossref","is-referenced-by-count":9,"title":["The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors"],"prefix":"10.3238","author":[{"given":"Norbert","family":"Bornfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Biewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Temming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zeschnigk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"10.3238\/arztebl.2018.0106_ref1","doi-asserted-by":"crossref","unstructured":"Kivela T: The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 2009; 93: 1129\u201331","DOI":"10.1136\/bjo.2008.150292"},{"key":"10.3238\/arztebl.2018.0106_ref2","unstructured":"Gr\u00e4f M: [Early detection of ocular disorders in children]. Dtsch Arztebl Int 2007; 104: 724\u20139"},{"key":"10.3238\/arztebl.2018.0106_ref3","unstructured":"Lohmann DR, Gallie BL: Retinoblastoma. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds.): GeneReviews(\u00ae. Seattle (WA): University of Washington, Seattle 1994\u20132017"},{"key":"10.3238\/arztebl.2018.0106_ref4","doi-asserted-by":"crossref","unstructured":"Temming P, Arendt M, Viehmann A, et al.: Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: a report from the German reference center. Pediatr Blood Cancer 2017; 64: 71\u201380","DOI":"10.1002\/pbc.26193"},{"key":"10.3238\/arztebl.2018.0106_ref5","doi-asserted-by":"crossref","unstructured":"Mitter D, Ullmann R, Muradyan A, et al.: Genotype-phenotype correlations in patients with retinoblastoma and interstitial 13q deletions. Eur J Hum Genet 2011; 19: 947\u201358","DOI":"10.1038\/ejhg.2011.58"},{"key":"10.3238\/arztebl.2018.0106_ref6","doi-asserted-by":"crossref","unstructured":"Temming P, Arendt M, Viehmann A, et al.: How eye-preserving therapy affects long-term overall survival in heritable retinoblastoma survivors. J Clin Oncol 2016; 34: 3183\u20138","DOI":"10.1200\/JCO.2015.65.4012"},{"key":"10.3238\/arztebl.2018.0106_ref7","doi-asserted-by":"crossref","unstructured":"Abramson DH, Shields CL, Munier FL, Chantada GL: Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmol 2015; 133: 1341\u20137","DOI":"10.1001\/jamaophthalmol.2015.3108"},{"key":"10.3238\/arztebl.2018.0106_ref8","doi-asserted-by":"crossref","unstructured":"Yousef YA, Soliman SE, Astudillo PP, et al.: Intra-arterial chemotherapy for retinoblastoma: a systematic review. JAMA Ophthalmol 2016. doi: 10.1001\/jamaophthalmol.2016.0244 [Epub ahead of print]","DOI":"10.1001\/jamaophthalmol.2016.0244"},{"key":"10.3238\/arztebl.2018.0106_ref9","doi-asserted-by":"crossref","unstructured":"Biewald E, Holdt M, Bornfeld N: Neue Therapiestrategien beim Retinoblastom: Nichtsystemische Chemotherapie. Ophthalmologe 2014; 111: 379\u201382","DOI":"10.1007\/s00347-014-3038-8"},{"key":"10.3238\/arztebl.2018.0106_ref10","doi-asserted-by":"crossref","unstructured":"Suzuki S, Aihara Y, Fujiwara M, Sano S, Kaneko A: Intravitreal injection of melphalan for intraocular retinoblastoma. Jpn J Ophthalmol 2015; 59: 164\u201372","DOI":"10.1007\/s10384-015-0378-0"},{"key":"10.3238\/arztebl.2018.0106_ref11","doi-asserted-by":"crossref","unstructured":"Hill JA, Kimani K, White A, et al.: Achieving optimal cancer outcomes in East Africa through multidisciplinary partnership: a case study of the Kenyan National Retinoblastoma Strategy Group. Global Health 2016; 12: 23","DOI":"10.1186\/s12992-016-0160-1"},{"key":"10.3238\/arztebl.2018.0106_ref12","doi-asserted-by":"crossref","unstructured":"Kivela T, Kujala E: Long-term risk of melanoma-related mortality after uveal melanoma. JAMA Ophthalmol 2016; 134: 238\u20139","DOI":"10.1001\/jamaophthalmol.2015.5233"},{"key":"10.3238\/arztebl.2018.0106_ref13","doi-asserted-by":"crossref","unstructured":"Kujala E, Makitie T, Kivela T: Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003; 44: 4651\u20139","DOI":"10.1167\/iovs.03-0538"},{"key":"10.3238\/arztebl.2018.0106_ref14","doi-asserted-by":"crossref","unstructured":"Prescher G, Bornfeld N, Becher R: Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst 1990; 82: 1765\u20139","DOI":"10.1093\/jnci\/82.22.1765"},{"key":"10.3238\/arztebl.2018.0106_ref15","doi-asserted-by":"crossref","unstructured":"Thomas S, Putter C, Weber S, Bornfeld N, Lohmann DR, Zeschnigk M: Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study. Br J Cancer 2012; 106: 1171\u20136","DOI":"10.1038\/bjc.2012.54"},{"key":"10.3238\/arztebl.2018.0106_ref16","doi-asserted-by":"crossref","unstructured":"van Raamsdonk CD, Bezrookove V, Green G, et al.: Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457: 599\u2013602","DOI":"10.1038\/nature07586"},{"key":"10.3238\/arztebl.2018.0106_ref17","doi-asserted-by":"crossref","unstructured":"van Raamsdonk CD, Griewank KG, Crosby MB, et al.: Mutations in GNA11 in uveal melanoma. N Engl J Med 2010; 363: 2191\u20139","DOI":"10.1056\/NEJMoa1000584"},{"key":"10.3238\/arztebl.2018.0106_ref18","doi-asserted-by":"crossref","unstructured":"Damato B: Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture. Eye (Lond) 2012; 26: 1157\u201372","DOI":"10.1038\/eye.2012.126"},{"key":"10.3238\/arztebl.2018.0106_ref19","doi-asserted-by":"crossref","unstructured":"Biewald E, Lautner H, Gok M, et al.: Endoresection of large uveal melanomas: clinical results in a consecutive series of 200 cases. Br J Ophthalmol 2017: 101: 204\u20138","DOI":"10.1136\/bjophthalmol-2015-307076"},{"key":"10.3238\/arztebl.2018.0106_ref20","doi-asserted-by":"crossref","unstructured":"Augsburger JJ, Correa ZM, Shaikh AH: Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 2009; 148: 119\u201327","DOI":"10.1016\/j.ajo.2009.01.023"},{"key":"10.3238\/arztebl.2018.0106_ref21","doi-asserted-by":"crossref","unstructured":"Schmittel AH, Schmidt-Hieber M, Bechrakis NE, et al.: A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma. J Clin Oncol 2006; 24: 8018","DOI":"10.1200\/jco.2006.24.18_suppl.8018"},{"key":"10.3238\/arztebl.2018.0106_ref22","doi-asserted-by":"crossref","unstructured":"Heusner TA, Antoch G, Wittkowski-Sterczewski A, et al.: Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment. Rofo 2011; 183: 1151\u201360","DOI":"10.1055\/s-0031-1281743"},{"key":"10.3238\/arztebl.2018.0106_ref23","doi-asserted-by":"crossref","unstructured":"Leyvraz S, Piperno-Neumann S, Suciu S, et al.: Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Ann Oncol 2014; 25: 742\u20136","DOI":"10.1093\/annonc\/mdt585"},{"key":"10.3238\/arztebl.2018.0106_ref24","doi-asserted-by":"crossref","unstructured":"Noter SL, Rothbarth J, Pijl ME, et al.: Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res 2004; 14: 67\u201372","DOI":"10.1097\/00008390-200402000-00011"},{"key":"10.3238\/arztebl.2018.0106_ref25","doi-asserted-by":"crossref","unstructured":"Algazi AP, Tsai KK, Shoushtari AN, et al.: Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies. Cancer 2016; 122: 3344\u201353","DOI":"10.1002\/cncr.30258"},{"key":"10.3238\/arztebl.2018.0106_ref26","doi-asserted-by":"crossref","unstructured":"Zuidervaart W, van Nieuwpoort F, Stark M, et al.: Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer 2005; 92: 2032\u20138","DOI":"10.1038\/sj.bjc.6602598"},{"key":"10.3238\/arztebl.2018.0106_ref27","doi-asserted-by":"crossref","unstructured":"Eliassi-Rad B, Albert DM, Green WR: Frequency of ocular metastases in patients dying of cancer in eye bank populations. Br J Ophthalmol 1996; 80: 125\u20138","DOI":"10.1136\/bjo.80.2.125"},{"key":"10.3238\/arztebl.2018.0106_ref28","unstructured":"Konstantinidis L, Damato B: Intraocular metastases\u2014a review. Asia Pac J Ophthalmol (Phila) 2017; 6: 208\u201314"},{"key":"10.3238\/arztebl.2018.0106_ref29","doi-asserted-by":"crossref","unstructured":"Arepalli S, Kaliki S, Shields CL: Choroidal metastases: origin, features, and therapy. Indian J Ophthalmol 2015; 63: 122\u20137","DOI":"10.4103\/0301-4738.154380"},{"key":"10.3238\/arztebl.2018.0106_ref30","doi-asserted-by":"crossref","unstructured":"Griewank KG, Schilling B, Scholz SL, et al.: Oncogene status as a diagnostic tool in ocular and cutaneous melanoma. Eur J Cancer 2016; 57: 112\u20137","DOI":"10.1016\/j.ejca.2016.01.010"},{"key":"10.3238\/arztebl.2018.0106_ref31","doi-asserted-by":"crossref","unstructured":"Shah SU, Mashayekhi A, Shields CL, et al.: Uveal metastasis from lung cancer clinical features, Treatment, and outcome in 194 patients. Ophthalmology 2014; 121: 352\u20137","DOI":"10.1016\/j.ophtha.2013.07.014"},{"key":"10.3238\/arztebl.2018.0106_ref32","doi-asserted-by":"crossref","unstructured":"Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE: Survey of 520 eyes with uveal metastases. Ophthalmology 1997; 104: 1265\u201376","DOI":"10.1016\/S0161-6420(97)30148-1"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:19:26Z","timestamp":1638796766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2018.0106","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,16]]}}}